Clinical outcome and prognostic factors for Asian patients in Phase I clinical trials

BACKGROUND: Patient selection is key in Phase I studies, and prognosis can be difficult to estimate in heavily pre-treated patients. Previous prognostic models like the Royal Marsden Hospital (RMH) score or using the neutrophil–lymphocyte ratio (NLR) have not been validated in current novel therapie...

Descripción completa

Detalles Bibliográficos
Autores principales: Loh, Jerold, Wu, Jiaxuan, Chieng, Jenny, Chan, Aurora, Yong, Wei-Peng, Sundar, Raghav, Lee, Soo-Chin, Wong, Andrea, Lim, Joline S. J., Tan, David S. P., Soo, Ross, Goh, Boon-Cher, Tai, Bee-Choo, Chee, Cheng E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070409/
https://www.ncbi.nlm.nih.gov/pubmed/36797357
http://dx.doi.org/10.1038/s41416-023-02193-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070409/
https://www.ncbi.nlm.nih.gov/pubmed/36797357
http://dx.doi.org/10.1038/s41416-023-02193-2

Ejemplares similares